Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...
NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.
CRISPR RID-MyC assay shows 82.1% sensitivity for diagnosing fungal keratitis in smear- and culture-negative patients.
CRISPR RID-MyC assay shows 82.1% sensitivity for diagnosing fungal keratitis in smear- and culture-negative patients.
CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...
Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...
In back-to-back studies published in Nature, researchers from Purdue University and Columbia University report a naturally evolved gene-editing system that can activate genes, offering an advantage ...
Renan is the Movies & TV Lead Editor for GameRant. Ren graduated Cum Laude from Lesley University in 2017 and has been focusing exclusively on his journalistic endeavors ever since. When Ren isn't ...
One year ago, a baby from Delaware County, Pennsylvania, became the first person in the world to receive a new revolutionary therapy at Children's Hospital of Philadelphia. "We didn't know that we ...
Casgevy is starting to build some serious sales momentum. CRISPR Therapeutics also has a deep pipeline and healthy funding. The stock requires patience, but there is a visible path to a bright future.
Gene editing is a numbers game. For any genetic tweaks to have notable impact, a sufficient number of targeted cells need to have the disease-causing gene deleted or replaced. Despite a growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results